Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics
NCT ID: NCT07288476
Last Updated: 2025-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
10 participants
INTERVENTIONAL
2026-01-31
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pilot educational videos
Pilot education videos with Spanish-speaking parents as a tool to improve caregiver knowledge, satisfaction, confidence in caring for their child, and level of overwhelm.
educational video
Spanish-language video to impart knowledge and understanding to parents caring for children with cancer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
educational video
Spanish-language video to impart knowledge and understanding to parents caring for children with cancer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Legal caregiver aged ≥18 years of a child/young adult (0-25 years) undergoing active cancer treatment in low-intensity phases or off therapy.
* Native or fluent Spanish speaker.
* Willing and able to provide verbal consent.
* Willing to comply with study procedures and be available for the study duration.
Aim 3 (Video Pilot Phase):
* Legal caregiver aged ≥18 years of a child/young adult (0-25 years) with newly diagnosed or relapsed/refractory cancer (≤1 month).N
* Native or fluent Spanish speaker.
* Requires an interpreter for medical conversations.
* Willing and able to provide verbal consent.
* Willing to comply with study procedures and be available for the study duration.
Exclusion Criteria
* Insufficient cognitive functioning to complete study procedures (as determined by PI).
* Caregiver of a child/young adult who did not receive cancer-directed therapy.
* Caregiver of a child/young adult receiving high-intensity cancer treatment.
* Unable to read and speak Spanish fluently.
Aim 3:
* Insufficient cognitive functioning to complete study measures (as determined by PI).Caregiver of a child/young adult who did not receive cancer-directed therapy.
* Caregiver of a child/young adult not receiving cancer-directed therapy.
* Diagnosis of new or relapsed/refractory cancer occurred \>1 month prior to enrollment.
* Unable to speak Spanish fluently.
* Does not require an interpreter for medical conversations.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital Colorado
Aurora, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Glenn Buck
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2025-08026
Identifier Type: OTHER
Identifier Source: secondary_id
25-0595.cc
Identifier Type: -
Identifier Source: org_study_id